S2851 Analyzing the Trends in Admissions Related to Autoimmune Hepatitis and the Growing Burden on Healthcare: A Decade-Long National Study From the USA

Introduction: Although some studies have suggested a rise in the incidence of autoimmune hepatitis (AIH), data regarding hospitalization trends and healthcare burden is sparse. In this retrospective study, we aimed to describe the trends in AIH among all-cause admissions in the United States over a decade and their growing healthcare burden. Methods: We analyzed the 2012-2021 NIS. The presence of autoimmune hepatitis was identified using International Classification of Diseases, Ninth and Tenth Revision (ICD-9/10) codes “K754”. We estimated the year-by-year trends in hospitalizations of AIH relative to all-cause admissions, stratified by sex, age, and race, using Cochran–Armitage tests. The inflation-adjusted total hospital costs (USD) were also compared over the 10 years. A logistic regression model estimated how age, sex, race, and year impacted the odds of having a higher than median cost of hospitalization. Results: From 2012 to 2021, AIH-related hospitalizations increased from 55.2 cases per 100,000 admissions to 80.1 per 100,000 (Ptrend < 0.01). Similar overall rising trends were noted based on sex, race, and age groups. Total costs rose from 290.5 million in 2012 to 477.2 million in 2021 (Ptrend < 0.01). Overall increments in cost were also observed in our stratified groups (Ptrend < 0.01 throughout). A multivariable regression model showed that the odds of reporting a hospital cost higher than median were higher among patients ages 46-59 years (aOR 1.317, 95% CI 1.283-1.352, P < 0.01) and ages ≥60 years (aOR 1.407, 95% CI 1.376-1.439, P < 0.01) (vs Ages 18-45). Racial disparities were also seen as Blacks (aOR 1.173, 95% CI 1.143-1.204, P < 0.01), Hispanics (aOR 1.346, 95% CI 1.311-1.382, P < 0.01), and Asian Americans/Pacific-Islanders (AAPI) (aOR 1.827, 95% CI 1.724-1.937, P < 0.01) tended to be more likely to report higher than median costs than Whites. The burden also followed an annual pattern (aOR 1.045, 95% CI 1.041-1.048, P < 0.01). AIH admissions was higher among women than men, they were less likely to report a hospital cost higher than the overall median (aOR 0.880, 95% CI 0.861-0.900, P < 0.01). Conclusion: This study confirmed that AIH is a growing healthcare concern and burden. In addition, racial, sex-based, and age-based discrepancies in hospital costs were found. This calls for additional studies to first identify at-risk groups for AIH and provide adequate screening and follow-ups to mitigate the risks of severe hospitalizations.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001138864.82915.2a
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S2851 Analyzing the Trends in Admissions Related to Autoimmune Hepatitis and the Growing Burden on Healthcare: A Decade-Long National Study From the USA

Wesam Frandah, Hafiz Zarsham Ali Ikram, Kamleshun Ramphul, Tejas Joshi et al.
The American Journal of Gastroenterology
Liver Diseases and Immunity
article

S2851 Analyzing the Trends in Admissions Related to Autoimmune Hepatitis and the Growing Burden on Healthcare: A Decade-Long National Study From the USA

Wesam Frandah, Hafiz Zarsham Ali Ikram, Kamleshun Ramphul, Tejas Joshi, Renuka Verma
article en

Abstract

Introduction: Although some studies have suggested a rise in the incidence of autoimmune hepatitis (AIH), data regarding hospitalization trends and healthcare burden is sparse. In this retrospective study, we aimed to describe the trends in AIH among all-cause admissions in the United States over a decade and their growing healthcare burden. Methods: We analyzed the 2012-2021 NIS. The presence of autoimmune hepatitis was identified using International Classification of Diseases, Ninth and Tenth Revision (ICD-9/10) codes “K754”. We estimated the year-by-year trends in hospitalizations of AIH relative to all-cause admissions, stratified by sex, age, and race, using Cochran–Armitage tests. The inflation-adjusted total hospital costs (USD) were also compared over the 10 years. A logistic regression model estimated how age, sex, race, and year impacted the odds of having a higher than median cost of hospitalization. Results: From 2012 to 2021, AIH-related hospitalizations increased from 55.2 cases per 100,000 admissions to 80.1 per 100,000 (Ptrend < 0.01). Similar overall rising trends were noted based on sex, race, and age groups. Total costs rose from 290.5 million in 2012 to 477.2 million in 2021 (Ptrend < 0.01). Overall increments in cost were also observed in our stratified groups (Ptrend < 0.01 throughout). A multivariable regression model showed that the odds of reporting a hospital cost higher than median were higher among patients ages 46-59 years (aOR 1.317, 95% CI 1.283-1.352, P < 0.01) and ages ≥60 years (aOR 1.407, 95% CI 1.376-1.439, P < 0.01) (vs Ages 18-45). Racial disparities were also seen as Blacks (aOR 1.173, 95% CI 1.143-1.204, P < 0.01), Hispanics (aOR 1.346, 95% CI 1.311-1.382, P < 0.01), and Asian Americans/Pacific-Islanders (AAPI) (aOR 1.827, 95% CI 1.724-1.937, P < 0.01) tended to be more likely to report higher than median costs than Whites. The burden also followed an annual pattern (aOR 1.045, 95% CI 1.041-1.048, P < 0.01). AIH admissions was higher among women than men, they were less likely to report a hospital cost higher than the overall median (aOR 0.880, 95% CI 0.861-0.900, P < 0.01). Conclusion: This study confirmed that AIH is a growing healthcare concern and burden. In addition, racial, sex-based, and age-based discrepancies in hospital costs were found. This calls for additional studies to first identify at-risk groups for AIH and provide adequate screening and follow-ups to mitigate the risks of severe hospitalizations.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 47%
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.